期刊文献+

子宫内膜异位症患者子宫内膜IL-18表达的研究 被引量:1

The study of expression of IL-18 in endometriosis
暂未订购
导出
摘要 目的 :研究子宫内膜异位症患者子宫在位内膜和异位内膜IL 18的表达 ,探讨IL 18在内异症发病机制中的意义。方法 :用免疫组化和半定量逆转录聚合酶链反应法检测对照组子宫内膜、子宫腺肌症患者子宫内膜和内异症患者的子宫在位内膜与异位内膜IL 18蛋白的表达位置及其mRNA表达水平。结果 :各组标本IL 18蛋白和mRNA的表达均阳性 ,内异症患者子宫在位内膜与异位内膜的IL 18mRNA表达水平分别为 1.0 5±0 .4 0、0 .77± 0 .39,均低于对照组子宫内膜 (1.6 5± 0 .6 4) ,差异有显著性 (P <0 .0 5 ) ;子宫腺肌症组IL 18mRNA表达水平为 1.6 3± 0 .6 0 ,与对照组子宫内膜IL 18mRNA表达水平差异无显著性。结论 :IL 18可能参与了子宫内膜异位症的发病 ,IL 18mRNA在内异症患者在位和异位内膜的低水平表达 ,可能是影响内异症形成和发展的重要因素之一。 Objective:To study the expression of IL-18 in eutopic and ectopic endometriun of endometriosis and the role on the pathogenesis of this disease.Methods:Endometrium specimens were obtained from 22 normal uteruses,26 with endometriosis and 21 with adenomyosis.Endometriosic tissues were obtained from 28 patients.Immunohistochemistry was employed to determine the location of IL-18 protein,and semiquantitative reverse transcriptase polymerase chain reaction,using β-actin as internal standard,was applied to determine the levels of IL-18 mRNA in those specimens.Results:IL-18 protein was found in all specimens and the expression of IL-18 mRNA was significantly lower in ectopic and eutopic endometrium from patients with endometriosis, compared with those from normal women and patients with adenomyosis (0.77±0.39, 1.05±0.40 and 1.65±0.64,1.63±0.60,respectively,P<0.05).In normal women,expression of IL-18 mRNA was higher in secretory endometrium than that in proliferative endometrium;whereas in endometriosic women,there was no difference.Conclusion:Women with endometriosis show down-regulation of IL-18 expression in ectopic and eutopic endometrium, and the abnormal expression may result in formation and continuing growth of ectopic locations.
出处 《现代妇产科进展》 CSCD 2004年第3期194-196,共3页 Progress in Obstetrics and Gynecology
关键词 子宫内膜异位症 白细胞介素18 子宫内膜 聚合酶链反应 Endometriosis Interleukin-18 Endometrium Polymerase chain reaction
  • 相关文献

参考文献7

  • 1Yoshino O,Osuga Y,Koga K, et al. Evidence for the expression of IL-18, IL-18 receptor and IL-18 binding protein in the human endometrium [J]. Mol Hum Reprod, 2001,7 (7): 649-654
  • 2Hsu CC, Yang BC, Wu MH, et al. Enhanced interleukin-4 expression in patients with endometriosis[J]. Fertil Steril, 1997,67(6): 1059-1064
  • 3Oosterlynck DJ,Meuleman C,Waer M,et al.Immunosuppressive activity of peritoneal fluid in women with endometriosis [J]. Am J Obstet Gynecol, 1993,82:206-212
  • 4Kanzaki H, Wang HS, Kariya M, et al. Suppression of natural killer cell activity by sera from patients with endometriosis [J] .Am J Obstet Gynecol, 1992,167:257-261
  • 5Hashimoto W, Osaki T, Okamura H, et al. Differential antitumor effects of administration of recombinant IL-18 or recombinam IL-12 are mediated primarily by Fas-Fas ligand and perforin-induced tumor apoptosis, respectively [J]. J Immtnol,1999,163(2) :583-589
  • 6Somigliana E, Vigano P, Rossi G, et al. Endometrial ability to implant in ectopic sites can be prevent by interleulin-12 in a murine model of endometriosis[J]. Hum Reprod, 1999, 14(12) :2944-2950
  • 7Chaouat G,Zourbas S,Ostojic S,et al.A brief review of recent data on some cytokine expressions at the matemo-foetal interface which might challenge the classical Th1/Th2 dichotomy [J]. J Reprod Immunol,2002,53(1-2) :241-256

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部